1. Home
  2. DOV vs ILMN Comparison

DOV vs ILMN Comparison

Compare DOV & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dover Corporation

DOV

Dover Corporation

HOLD

Current Price

$196.31

Market Cap

26.8B

Sector

Industrials

ML Signal

HOLD

Logo Illumina Inc.

ILMN

Illumina Inc.

HOLD

Current Price

$134.14

Market Cap

20.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DOV
ILMN
Founded
1947
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
26.8B
20.5B
IPO Year
N/A
2000

Fundamental Metrics

Financial Performance
Metric
DOV
ILMN
Price
$196.31
$134.14
Analyst Decision
Buy
Hold
Analyst Count
10
16
Target Price
$217.70
$117.31
AVG Volume (30 Days)
990.2K
1.5M
Earning Date
01-29-2026
02-05-2026
Dividend Yield
1.06%
N/A
EPS Growth
45.52
N/A
EPS
16.27
4.46
Revenue
$7,923,358,000.00
$4,288,000,000.00
Revenue This Year
$5.31
N/A
Revenue Next Year
$5.52
$2.24
P/E Ratio
$25.50
$30.12
Revenue Growth
2.62
N/A
52 Week Low
$143.04
$68.70
52 Week High
$222.31
$153.06

Technical Indicators

Market Signals
Indicator
DOV
ILMN
Relative Strength Index (RSI) 55.99 57.78
Support Level $195.12 $132.93
Resistance Level $200.92 $135.95
Average True Range (ATR) 2.92 3.28
MACD -0.84 -0.85
Stochastic Oscillator 23.28 50.37

Price Performance

Historical Comparison
DOV
ILMN

About DOV Dover Corporation

Founded in 1955 by George Ohrstrom, Dover has become an industrial behemoth through the acquisition of dozens of esteemed brands. The company is organized into five segments through which it designs and manufactures highly engineered components, such as vehicle repair, factory automation, welding, aerospace, fuel dispensing, printing, liquid handling, refrigeration, and can-making equipment. It has operations around the globe but generates over half of its revenue in the United States.

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Share on Social Networks: